Fluoroquinolone resistance in Escherichia coli isolated from patients attending Canadian hospitals is associated with the ST131 clone

Diagnostic Microbiology and Infectious Disease

Volumn 71, Issue 3, 2011, Pages 323-324

  Simner, Patricia J ^a   Hoban, Daryl J ^b   Lagacé Wiens, Philippe R S ^c   Zhanel, George G ^a   Karlowsky, James A ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

^c ST BONIFACE GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIUM ISOLATE; CANADA; CLONE; CONTROLLED STUDY; ESCHERICHIA COLI; GENE AMPLIFICATION; LETTER; NONHUMAN; PABB GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; CANADA; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FLUOROQUINOLONES; GENOTYPING TECHNIQUES; HUMANS;

EID: 80053892915     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2011.07.016     Document Type: Letter

References (11)

1. Baudry-Simner P.J., Singh A., Karlowsky J.A., the Canadian Antimicrobial Resistance Alliance, Hoban D.J., Zhanel G.G. Mechanisms of reduced susceptibility to ciprofloxacin in Escherichia coli isolates from Canadian hospitals. Can J Infect Dis Med Microbiol 2011, (in press).
2. Clermont O., Dhanji H., Upton M., Gibreel T., Fox A., Boyd D., Mulvey M.R., Nordmann P., Ruppe E., Sarthou J.L., Frank T., Vimont S., Arlet G., Branger C., Woodford N., Denamur E. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother 2009, 64:274-277.
3. Johnson J.R., Menard M., Johnston B., Kuckowski M.A., Nichol K., Zhanel G.G. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother 2009, 53:2733-2739.
4. Karlowsky J.A., Lagacé-Wiens P.R.S., Simner P.J., DeCorby M.R., Adam H.J., Walkty A., Hoban D.J., Zhanel G.G. Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study. Antimicrob Agents Chemother 2011, 55:3169-3175.
5. Manges A.R., Tabor H., Tellis P., Vincent C., Tellier P.P. Endemic and epidemic lineages of Escherichia coli that cause urinary tract infections. Emerg Infect Dis 2008, 14:1575-1583.
6. Peirano G., Richardson D., Nigrin J., McGeer A., Loo V., Toye B., Alfa M., Pienaar C., Kibsey P., Pitout J.D. High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada. Antimicrob Agents Chemother 2010, 54:1327-1330.
7. Pitout J.D., Gregson D.B., Campbell L., Laupland K.B. Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob Agents Chemother 2009, 53:2846-2851.
8. Rogers B.A., Sidjabat H.E., Paterson D.L. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 2011, 66:1-14.
9. Simner P.J., Zhanel G.G., Pitout J., Tailor F., McCracken M., Mulvey M.R., Lagacé-Wiens P.R.S., Adam H.J., Hoban D.J., the Canadian Antimicrobial Resistance Alliance (CARA) Prevalence and characterization of extended-spectrum β-lactamase- and AmpC β-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study. Diagn Microbiol Infect Dis 2011, 69:326-334.
10. Zhanel G.G., DeCorby M., Laing N., Weshnoweski B., Vashisht R., Tailor F., Nichol K.A., Wierzbowski A., Baudry P.J., Karlowsky J.A., Lagace-Wiens P., Walkty A., McCracken M., Mulvey M.R., Johnson J., Hoban D.J. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Antimicrob Agents Chemother 2008, 52:1430-1437.
11. Zhanel G.G., Adam H.J., Low D.E., Blondeau J., DeCorby M., Karlowsky J.A., Weshnoweski B., Vashisht R., Wierzbowski A., Hoban D.J., the Canadian Antimicrobial Resistance Alliance (CARA) Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: results of the CANWARD 2007-2009 study. Diagn Microbiol Infect Dis 2011, 69:291-306.